TRVI — Trevi Therapeutics, Inc. | XLV Holdings | StockAdder

(TRVI)

Trevi Therapeutics, Inc.

Live chart and latest TRVI stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

TRVI News

Trevi Therapeutics (TRVI) asks shareholders to approve stock-plan refresh and share increase

Apr 10, 2026 Yahoo Finance

A Look At Trevi Therapeutics (TRVI) Valuation After FDA Green Light For Phase 3 Trials

Mar 15, 2026 MarketBeat

Trevi Therapeutics (NASDAQ:TRVI) Trading Up 7.2% - Here's What Happened

Apr 6, 2026 PR Newswire

Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

Jun 3, 2025 Investing.com

Cantor Fitzgerald reiterates Trevi Therapeutics stock Overweight rating

Mar 18, 2026 Quiver Quantitative

TREVI THERAPEUTICS ($TRVI) Releases Q4 2025 Earnings

Mar 17, 2026 simplywall.st

Assessing Trevi Therapeutics (TRVI) Valuation After FDA Alignment On Phase 3 IPF Chronic Cough Program

Mar 16, 2026 GlobeNewswire

Trevi Therapeutics to Participate in Upcoming Events

Apr 1, 2026 Stock Titan

Trevi brings chronic cough specialists to New York investor day

Apr 1, 2026 MarketBeat

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of "Buy" from Analysts

Mar 28, 2026 Yahoo Finance

Trevi Therapeutics Inc (TRVI) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...

Nov 13, 2025 Stock Titan

Vanguard (TRVI) amends 13G/A after Jan 12, 2026 realignment

Mar 27, 2026 Yahoo Finance

Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change

Dec 21, 2025 MarketBeat

Trevi Therapeutics (NASDAQ:TRVI) Shares Up 9.4% - What's Next?

Mar 25, 2026 Yahoo Finance

Trevi Therapeutics (TRVI) Valuation Check After FDA End Of Phase 2 Update And Renewed Analyst Optimism